CREDIT SUISSE AG/ - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 72 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$97,000
+24.4%
17,540
-55.0%
0.00%
Q3 2016$78,000
-47.7%
39,018
+83.7%
0.00%
Q4 2014$149,00021,2370.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,192,080$9,704,0004.11%
Ghost Tree Capital, LLC 219,977$1,790,0001.06%
JBF Capital, Inc. 148,178$1,205,0000.18%
Polar Capital LLP 900,604$7,326,0000.17%
SPHERA FUNDS MANAGEMENT LTD. 80,000$651,0000.15%
HAMILTON LANE ADVISORS LLC 33,141$270,0000.11%
Jasper Ridge Partners, L.P. 63,996$521,0000.03%
Weiss Multi-Strategy Advisers LLC 95,000$773,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 550,000$4,474,0000.01%
AXA S.A. 292,625$2,381,0000.01%
View complete list of CONATUS PHARMACEUTICALS INC shareholders